▶ 調査レポート

世界のグリコミクス市場2021-2031:製品種類別(酵素、機器、キット、試薬)、用途別、エンドユーザー別

• 英文タイトル:Glycomics Market (Product Type: Enzymes, Instruments, Kits, and Reagents; Application: Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others; and End-user: Academic Research Institutes, Pharmaceutical and & Biotechnology Companies, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。世界のグリコミクス市場2021-2031:製品種類別(酵素、機器、キット、試薬)、用途別、エンドユーザー別 / Glycomics Market (Product Type: Enzymes, Instruments, Kits, and Reagents; Application: Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others; and End-user: Academic Research Institutes, Pharmaceutical and & Biotechnology Companies, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / TMR2201B042資料のイメージです。• レポートコード:TMR2201B042
• 出版社/出版日:Transparency Market Research / 2021年11月16日
• レポート形態:英文、PDF、224ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Site Licence¥1,301,660 (USD8,795)▷ お問い合わせ
  Enterprisewide¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界のグリコミクス市場を調査・分析し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別(酵素、機器、キット、試薬)分析、用途別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のグリコミクス市場規模:製品種類別(酵素、機器、キット、試薬)
・世界のグリコミクス市場規模:用途別
・世界のグリコミクス市場規模:エンドユーザー別
・世界のグリコミクス市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Glycomics Market – Scope of Report

TMR’s report on the global glycomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall market revenue of the global glycomics market for the period 2017–2031, considering 2017 to 2019 as historical years, 2020 as the base year, and 2021 to 2031 as the forecast period. The report also provides the compound annual growth rate (CAGR) of the global glycomics market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global glycomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a top-down approach to study various phenomena in the global glycomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global glycomics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global glycomics market. The next section of the global glycomics market report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, and key developments in the global glycomics market.

The report delves into the competitive landscape of the global glycomics market. Key players operating in the global glycomics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global glycomics market profiled in this report.

Key Questions Answered in Glycomics Market Report

What are the major drivers, restraints, and opportunities in the global market?
What will be the revenue share projections of key segments of the global glycomics market during the forecast period?
Which segment is likely to lead the global glycomics market in terms of revenue by 2031?
How mergers & acquisitions among players are widening the scope of the global glycomics market?
Which are the leading companies in the global glycomics market?
Glycomics Market – Research Objectives and Research Approach

The comprehensive report on the global glycomics market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the glycomics market. It is followed by market introduction, market dynamics, and an overview of the global glycomics market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global glycomics market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the glycomics market. The next section of the glycomics market report highlights the USPs, which include technology snapshot, process overview, prominent software tools, key industry developments, regulatory scenario, and reimbursement scenario in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global glycomics market in terms of product type, application, end-user, and region. Key segments under each criteria have been studied at length, and the market share of each of them at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the glycomics market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Glycomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Glycomics Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Glycomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Enzymes
6.3.1.1. Glycosidases
6.3.1.2. Glycosyltransferases
6.3.1.3. Neuraminidases
6.3.1.4. Sialyltransferases
6.3.1.5. Others
6.3.2. Instruments
6.3.2.1. Antibody Arrays
6.3.2.2. HPLC
6.3.2.3. Lectin Arrays
6.3.2.4. MALDI-TOF
6.3.2.5. Other Glycomics Instruments
6.3.3. Kits
6.3.3.1. Glycan Labeling Kits
6.3.3.2. Glycan Purification Kits
6.3.3.3. Glycan Release Kits
6.3.3.4. Others
6.3.4. Reagents
6.3.4.1. Glycoproteins
6.3.4.2. Monosaccharides
6.3.4.3. Oligosaccharides
6.3.4.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glycomics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnostics
7.3.2. Drug Discovery & Development
7.3.3. Oncology
7.3.4. Immunology
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Glycomics Market Analysis and Forecast End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Academic Research Institute
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Contract Research Organizations
8.4. Market Attractiveness Analysis, by End-user
9. Global Glycomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Glycomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Enzymes
10.2.1.1. Glycosidases
10.2.1.2. Glycosyltransferases
10.2.1.3. Neuraminidases
10.2.1.4. Sialyltransferases
10.2.1.5. Others
10.2.2. Instruments
10.2.2.1. Antibody Arrays
10.2.2.2. HPLC
10.2.2.3. Lectin Arrays
10.2.2.4. MALDI-TOF
10.2.2.5. Other Glycomics Instruments
10.2.3. Kits
10.2.3.1. Glycan Labeling Kits
10.2.3.2. Glycan Purification Kits
10.2.3.3. Glycan Release Kits
10.2.3.4. Others
10.2.4. Reagents
10.2.4.1. Glycoproteins
10.2.4.2. Monosaccharides
10.2.4.3. Oligosaccharides
10.2.4.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnostics
10.3.2. Drug Discovery & Development
10.3.3. Oncology
10.3.4. Immunology
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Academic Research Institute
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Glycomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Enzymes
11.2.1.1. Glycosidases
11.2.1.2. Glycosyltransferases
11.2.1.3. Neuraminidases
11.2.1.4. Sialyltransferases
11.2.1.5. Others
11.2.2. Instruments
11.2.2.1. Antibody Arrays
11.2.2.2. HPLC
11.2.2.3. Lectin Arrays
11.2.2.4. MALDI-TOF
11.2.2.5. Other Glycomics Instruments
11.2.3. Kits
11.2.3.1. Glycan Labeling Kits
11.2.3.2. Glycan Purification Kits
11.2.3.3. Glycan Release Kits
11.2.3.4. Others
11.2.4. Reagents
11.2.4.1. Glycoproteins
11.2.4.2. Monosaccharides
11.2.4.3. Oligosaccharides
11.2.4.4. Others
11.3. Market Value Forecast Application, 2017–2031
11.3.1. Diagnostics
11.3.2. Drug Discovery & Development
11.3.3. Oncology
11.3.4. Immunology
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Academic Research Institute
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Glycomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Enzymes
12.2.1.1. Glycosidases
12.2.1.2. Glycosyltransferases
12.2.1.3. Neuraminidases
12.2.1.4. Sialyltransferases
12.2.1.5. Others
12.2.2. Instruments
12.2.2.1. Antibody Arrays
12.2.2.2. HPLC
12.2.2.3. Lectin Arrays
12.2.2.4. MALDI-TOF
12.2.2.5. Other Glycomics Instruments
12.2.3. Kits
12.2.3.1. Glycan Labeling Kits
12.2.3.2. Glycan Purification Kits
12.2.3.3. Glycan Release Kits
12.2.3.4. Others
12.2.4. Reagents
12.2.4.1. Glycoproteins
12.2.4.2. Monosaccharides
12.2.4.3. Oligosaccharides
12.2.4.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnostics
12.3.2. Drug Discovery & Development
12.3.3. Oncology
12.3.4. Immunology
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Academic Research Institute
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Glycomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Enzymes
13.2.1.1. Glycosidases
13.2.1.2. Glycosyltransferases
13.2.1.3. Neuraminidases
13.2.1.4. Sialyltransferases
13.2.1.5. Others
13.2.2. Instruments
13.2.2.1. Antibody Arrays
13.2.2.2. HPLC
13.2.2.3. Lectin Arrays
13.2.2.4. MALDI-TOF
13.2.2.5. Other Glycomics Instruments
13.2.3. Kits
13.2.3.1. Glycan Labeling Kits
13.2.3.2. Glycan Purification Kits
13.2.3.3. Glycan Release Kits
13.2.3.4. Others
13.2.4. Reagents
13.2.4.1. Glycoproteins
13.2.4.2. Monosaccharides
13.2.4.3. Oligosaccharides
13.2.4.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnostics
13.3.2. Drug Discovery & Development
13.3.3. Oncology
13.3.4. Immunology
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Academic Research Institute
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Glycomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Enzymes
14.2.1.1. Glycosidases
14.2.1.2. Glycosyltransferases
14.2.1.3. Neuraminidases
14.2.1.4. Sialyltransferases
14.2.1.5. Others
14.2.2. Instruments
14.2.2.1. Antibody Arrays
14.2.2.2. HPLC
14.2.2.3. Lectin Arrays
14.2.2.4. MALDI-TOF
14.2.2.5. Other Glycomics Instruments
14.2.3. Kits
14.2.3.1. Glycan Labeling Kits
14.2.3.2. Glycan Purification Kits
14.2.3.3. Glycan Release Kits
14.2.3.4. Others
14.2.4. Reagents
14.2.4.1. Glycoproteins
14.2.4.2. Monosaccharides
14.2.4.3. Oligosaccharides
14.2.4.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnostics
14.3.2. Drug Discovery & Development
14.3.3. Oncology
14.3.4. Immunology
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Academic Research Institute
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Agilent Technologies, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Asparia Glycomics
15.4.2.1. Company Description
15.4.2.2. SWOT Analysis
15.4.3. Bruker Corporation
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Canadian Glycomics Network (GLYCONET)
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. SWOT Analysis
15.4.5. Glyco Expression Technologies, Inc.
15.4.5.1. Company Description
15.4.5.2. SWOT Analysis
15.4.6. Glycodiag
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Merck KGaA
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. Financial Overview
15.4.7.4. SWOT Analysis
15.4.8. New England Biolabs
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. SWOT Analysis
15.4.9. RayBiotech, Inc.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Shimadzu Corporation
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. Thermo Fisher Scientific, Inc.
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. Vector Laboratories
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. SWOT Analysis
15.4.13. Glyde Bio, Inc.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis

List of Tables

Table 01: Global Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 03: Global Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 04: Global Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 05: Global Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 06: Global Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 07: Global Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 08: Global Glycomics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Glycomics Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: North America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 12: North America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 13: North America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 14: North America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 15: North America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 16: North America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 17: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Europe Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 20: Europe Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 21: Europe Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 22: Europe Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 23: Europe Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Europe Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 25: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 28: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 29: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 30: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 31: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 32: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 33: Latin America Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 35: Latin America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 36: Latin America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 37: Latin America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 38: Latin America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 39: Latin America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 40: Latin America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 41: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 43: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 44: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 45: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 46: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 47: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 48: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031